1. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience

   • F. De Ponti
   • E. Poluzzi
   • N. Montanaro

   REVIEW ARTICLE Pages: 1 - 18

2. The use of fixed-mixture insulins in clinical practice

   • H. E. Turner
   • D. R. Matthews

   SPECIAL ARTICLE Pages: 19 - 25

3. Evidence of clinical efficacy of homeopathy

   • M. Cucherat
   • M. C. Haugh
   • for the HMRAG group

   SPECIAL ARTICLE Pages: 27 - 33

4. Nilvadipine protects low-density lipoprotein cholesterol from in vivo oxidation in hypertensive patients with risk factors for atherosclerosis

   • M. Inouye
   • T. Mio
   • K. Sumino

   PHARMACODYNAMICS Pages: 35 - 41

5. Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics

   • R. Wacke
   • B. Rohde
   • B. Drewelow

   PHARMACOKINETICS AND DISPOSITION Pages: 43 - 48

6. Pharmacokinetics of intravenous ATP in cancer patients

   • H. J. Agteresch
   • P. C. Dagnelie
   • J. H. P. Wilson

   PHARMACOKINETICS AND DISPOSITION Pages: 49 - 55

7. The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisolone

   • T. Varis
   • K. T. Kivistö
   • P. J. Neuvonen

   PHARMACOKINETICS AND DISPOSITION Pages: 57 - 60

8. Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes

   • S. Schmaldienst
   • F. Traunmüller
   • F. Thalhammer

   PHARMACOKINETICS AND DISPOSITION Pages: 61 - 64

9. Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the single CYP2C9 ^* 3 allele

   • J. Shimamoto
   • I. Ieiri
   • S. Higuchi

   PHARMACOKINETICS AND DISPOSITION Pages: 65 - 68

10. Influence of renal function on the pharmacokinetics of cerivastatin in normocholesterolemic adults

    • A. L. Mazzu
    • J. T. Lettieri
    • P. Sundaresan

    PHARMACOKINETICS AND DISPOSITION Pages: 69 - 74

11. Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study

    • J. Wójcicki
    • G. Wojciechowski
    • K. Kozlowski

    PHARMACOKINETICS AND DISPOSITION Pages: 75 - 79

12. Inhibition of human liver phenol sulfotransferase by nonsteroidal anti-inflammatory drugs

    • M. Vietri
    • C. De Santi
    • G. M. Pacifici

    PHARMACOKINETICS AND DISPOSITION Pages: 81 - 87

13. Pharmacokinetics and pharmacodynamics of propofol 6% SAZN versus propofol 1% SAZN and Diprivan-10 for short-term sedation following coronary artery bypass surgery

    • C. A. J. Knibbe
    • L. P. H. J. Aarts
    • M. Danhof

    PHARMACOKINETICS AND DISPOSITION Pages: 89 - 95

14. Antibiotic utilization at the university hospital after introducing an antibiotic policy

    • V. Vlahovic-Palcevski
    • M. Morovic
    • G. Palcevski

    PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 97 - 101

15. Workplace drug testing (WDT) likely to increase in Europe

    • P. Dalén
    • O. Beck
    • F. Sjöqvist

    CONFERENCE REPORT Pages: 103 - 120